Background: The aim of this study was to determine the incidence, outcomes, and risk factors for synechia formation after endoscopic sinus surgery (ESS) and middle turbinate medialization with and without FloSeal.
Methods: A retrospective review was performed of patients who underwent primary ESS with middle turbinate medialization, with or without the placement of FloSeal. Medialization was performed with the placement of an absorbable conchopexy suture and silastic splint. Operative variables and outcomes were analyzed to identify risk factors for synechia formation.
Results: One hundred thirty-five patients underwent medialization alone and 37 patients underwent medialization with placement of FloSeal. Overall, synechia formation was noted in 16 patients (9.3%). A statistically significant higher incidence of synechia formation was noted in patients who underwent middle turbinate medialization with the placement of FloSeal versus medialization alone (18.9% versus 6.7%). The incidences of intraoperative complications (6.2% versus 4.7%) and postoperative complications (6.2% versus 7%) were similar between patients with and without synechia, respectively. Patients experiencing synechia, however, underwent a statistically significant higher rate of revision procedures (25% versus 5.1%).
Conclusion: Despite adequate prevention with middle turbinate medialization, synechia formation after ESS may result in higher rates of revision procedures. The placement of FloSeal in conjunction with middle turbinate medialization may result in a higher incidence of synechia formation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2500/ajr.2007.21.2986 | DOI Listing |
Objectives: This review aims to evaluate the utility of nonmedicated middle meatal packing compared to no packing on synechia formation up to 12 weeks after endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS).
Methods: We conducted a systematic review according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A literature search was performed on Medline (PubMed), EBSCO CINAHL plus, CENTRAL, and Clinicaltrials.
Int J Surg Case Rep
December 2024
Pediatric Ophthalmic Pathology Department, SI "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine", 49/51 Frantsuzkyi Bulvar, Odesa 65015, Ukraine.
Introduction: Idiopathic congenital acorea is extremely rare. There are several techniques for preserving the clear lens during pupil formation.
Case Presentation: The complete pupil absence caused acute glaucoma attack 2 weeks after birth, which was controlled in a 1-month-old child by peripheral iridectomy and disconnecting iris-corneal synechias.
J Minim Invasive Gynecol
October 2024
Gynecology and Obstetrics Department, Angers University Hospital, Angers, France (all authors).
Vestn Otorinolaringol
August 2024
Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Moscow, Russia.
J Med Cases
August 2024
Department of Pathology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama City 700-8558, Japan.
Primary myelofibrosis shows widespread fibrosis in the bone marrow and is part of myeloproliferative neoplasms in which gene mutations in hematopoietic stem cells lead to abnormal clonal expansion of one or more lineage of myeloid and erythroid cells and megakaryocytes. Janus kinase (JAK) inhibitors are the main therapeutic regimen for primary myelofibrosis which harbors gene mutations, resulting in continuous activation of JAK-STAT signaling pathway. Since JAK inhibitors modulate immunological state, the administration would have a potential for uveitis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!